Tipranavir
Tipranavir (pronunciation: tip-RA-na-vir) is a type of antiretroviral medication used in the treatment of HIV/AIDS. It belongs to the class of drugs known as protease inhibitors (PIs), which work by blocking the action of an enzyme called protease that HIV needs to multiply in the body.
Etymology
The name "Tipranavir" is derived from the chemical structure of the drug, which is a tripeptide derivative. The "Tipra" part of the name comes from "tripeptide", and "navir" is a common suffix used for protease inhibitors.
Usage
Tipranavir is used in combination with other antiretroviral medications to treat HIV infection. It is typically used in patients who have tried other treatments without success. The drug is taken orally, usually twice a day.
Side Effects
Like all medications, Tipranavir can cause side effects. Common side effects include nausea, vomiting, diarrhea, and rash. More serious side effects can include liver problems and increased bleeding in people with hemophilia.
Related Terms
- Antiretroviral therapy: The use of medications to treat HIV/AIDS.
- Protease: An enzyme that HIV needs to multiply in the body.
- Protease inhibitor: A type of antiretroviral medication that blocks the action of protease.
- Hemophilia: A medical condition that affects the body's ability to control blood clotting.
External links
- Medical encyclopedia article on Tipranavir
- Wikipedia's article - Tipranavir
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski